The new research, published in Stroke, investigated what happens when COVID-19 interacts with the brain's endothelial cells. 

The study, published in the Journal of Invasive Cardiology, highlights the pandemic's continued impact on healthcare providers. 

BioTelemetry made $439 million in sales in 2019, with a significant portion of that coming from solutions related to heart rhythm disorders.

The new analysis, published in Circulation: Arrhythmia and Electrophysiology, was designed to help patients stay informed and avoid unnecessary stress during this challenging time. 

The new document, published in both the Journal of the American College of Cardiology and Circulation, highlights the significant progress researchers and clinicians have made in this area in recent years.

The noninvasive treatment option could potentially improve care for many patients, including those scheduled to undergo TAVR. 

The NIH-funded study was published in Arteriosclerosis, Thrombosis and Vascular Biology.

Researchers noted that these patients received care in the same hospitals and were treated by the same physicians. So why the difference in outcomes? 

Researchers found that a simple three-part intervention could help patients feel more at ease about their results. 

The study’s authors tracked data from more than 13,000 patients with malignant melanoma and more than 25,000 patients with lung cancer.